FR2837838B1 - Nouvelle cible moleculaire de la neurotoxicite - Google Patents

Nouvelle cible moleculaire de la neurotoxicite

Info

Publication number
FR2837838B1
FR2837838B1 FR0203792A FR0203792A FR2837838B1 FR 2837838 B1 FR2837838 B1 FR 2837838B1 FR 0203792 A FR0203792 A FR 0203792A FR 0203792 A FR0203792 A FR 0203792A FR 2837838 B1 FR2837838 B1 FR 2837838B1
Authority
FR
France
Prior art keywords
neurotoxicity
molecular target
novel molecular
novel
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0203792A
Other languages
English (en)
Other versions
FR2837838A1 (fr
Inventor
Fabien Schweighoffer
Annelies Resink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExonHit Therapeutics SA
Original Assignee
ExonHit Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0203792A priority Critical patent/FR2837838B1/fr
Application filed by ExonHit Therapeutics SA filed Critical ExonHit Therapeutics SA
Priority to CA002480016A priority patent/CA2480016A1/fr
Priority to EP03738196A priority patent/EP1488005A1/fr
Priority to PCT/FR2003/000940 priority patent/WO2003080864A1/fr
Priority to US10/502,754 priority patent/US20050009030A1/en
Priority to JP2003578588A priority patent/JP2005520557A/ja
Priority to AU2003244713A priority patent/AU2003244713A1/en
Publication of FR2837838A1 publication Critical patent/FR2837838A1/fr
Application granted granted Critical
Publication of FR2837838B1 publication Critical patent/FR2837838B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0203792A 2002-03-26 2002-03-26 Nouvelle cible moleculaire de la neurotoxicite Expired - Fee Related FR2837838B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0203792A FR2837838B1 (fr) 2002-03-26 2002-03-26 Nouvelle cible moleculaire de la neurotoxicite
EP03738196A EP1488005A1 (fr) 2002-03-26 2003-03-25 Histone deacetylase : nouvelle cible moleculaire de la neurotoxicite
PCT/FR2003/000940 WO2003080864A1 (fr) 2002-03-26 2003-03-25 Histone deacetylase: nouvelle cible moleculaire de la neurotoxicite
US10/502,754 US20050009030A1 (en) 2002-03-26 2003-03-25 Histone deacetylase: novel molecular target of neurotoxicity
CA002480016A CA2480016A1 (fr) 2002-03-26 2003-03-25 Histone deacetylase: nouvelle cible moleculaire de la neurotoxicite
JP2003578588A JP2005520557A (ja) 2002-03-26 2003-03-25 ヒストンデアセチラーゼ：神経毒性の新規な分子標的
AU2003244713A AU2003244713A1 (en) 2002-03-26 2003-03-25 Histone deacetylase: novel molecular target of neurotoxicity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203792A FR2837838B1 (fr) 2002-03-26 2002-03-26 Nouvelle cible moleculaire de la neurotoxicite

Publications (2)

Publication Number Publication Date
FR2837838A1 FR2837838A1 (fr) 2003-10-03
FR2837838B1 true FR2837838B1 (fr) 2005-01-28

Family

ID=27839220

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0203792A Expired - Fee Related FR2837838B1 (fr) 2002-03-26 2002-03-26 Nouvelle cible moleculaire de la neurotoxicite

Country Status (1)

Country Link
FR (1) FR2837838B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2366408A1 (fr) * 1999-05-03 2000-11-30 Methylgene, Inc. Inhibition d'histone deacetylase
AU7108400A (en) * 1999-09-03 2001-04-10 Salk Institute For Biological Studies, The Modulation of gene expression by modulating histone acetylation
FR2810995A1 (fr) * 2000-06-29 2002-01-04 Exonhit Therapeutics Sa Compositions et methodes pour le traitement ou la detection de pathologies neurodegeneratives

Also Published As

Publication number Publication date
FR2837838A1 (fr) 2003-10-03

Similar Documents

Publication Publication Date Title
DE602004002310D1 (de) Ortungssystem
NO20035428D0 (no) Nye anti-ineffektiver
NO20034992D0 (no) Nye 4-aninlinokinolin-3-karboksamider
NO20054224D0 (no) Nye 2-pyridinkarboksamidderivater
NO20034308L (no) Nye tyrokinase-inhibitorer
ATE511510T1 (de) Kondensierte azol-pyrimidin-derivate
DE602004021513D1 (de) Klimatisierungssystem
DE60216027D1 (de) Ortungssystem
DE602004021750D1 (de) Zweistrahlsystem
DE60228656D1 (de) Polymilchsäurefaser
DE50308694D1 (de) Bestrahlungsger t
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DE60235008D1 (de) Ringförmiges sputtertarget
NO20034695D0 (no) Nye sammensetninger
DE50306343D1 (de) Signalsäule
DE602004006719D1 (de) Kühlsystem
NO20041185L (no) Nye sykloheksylsulfoner
NO20030657L (no) Nye aminocykloheksanderivater
DE50303886D1 (de) Tragarm
NO20035248D0 (no) Nye fenylalkyloksy-fenyl derivater
DE602004018565D1 (de) Wärmeempfindliche, Cyanoacrylat-Polymere enthaltende Zusammensetzungen
FR2837838B1 (fr) Nouvelle cible moleculaire de la neurotoxicite
NO20025902L (no) Nye fenylpiperaziner
UY28661A1 (es) Derivados de cromano
ATE348799T1 (de) Substituierte cyclohexanderivate

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091130